SIGMUND ROGICH - 05 Jan 2026 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
Director
Signature
/s/ Joanne Wendy Kim, attorney-in-fact for Sigmund Rogich
Issuer symbol
BIVI
Transactions as of
05 Jan 2026
Net transactions value
$0
Form type
4
Filing time
09 Jan 2026, 17:02:46 UTC
Previous filing
07 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ROGICH SIGMUND Director C/O BIOVIE INC., 680 W NYE LANE STE 201, CARSON CITY /s/ Joanne Wendy Kim, attorney-in-fact for Sigmund Rogich 09 Jan 2026 0001168218

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIVI Stock Option (right to buy) Award $0 +70,000 $0.000000 70,000 05 Jan 2026 Common Stock 70,000 $1.31 Direct F1
transaction BIVI Stock Option (right to buy) Award $0 +141,100 $0.000000 141,100 05 Jan 2026 Common Stock 141,100 $1.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.
F2 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029.